Filter:
In light of the Public Health Emergency concerning the coronavirus disease 2019 (COVID-19), the Office for Civil Rights (OCR) at […]
Read More… from BULLETIN: Civil Rights, HIPAA, and the Coronavirus Disease 2019 (COVID-19)
As a global pharmaceutical leader, we are doing all we can to protect the health of our employees, their families […]
A team of more than 50 volunteers at the Center for Regenerative Medicine (CReM) on Boston University’s Medical Campus, directed by Alpha doctor, […]
March 26, 2020 Early this morning, the Senate passed a $2 trillion COVID-19 relief bill. The Bill (S. 3548) is […]
Read More… from CARES ACT Bill (S.3548) passed by The Senate
Barcelona, March 25, 2020 – Grifols today announces that it has entered into a formal collaboration with the United States […]
Because of COVID-19’s impacts on the lungs, the U.S. Alpha-1 Foundation has provided detailed, specific guidance for patients who have alpha […]
Read More… from Coronavirus: Alpha 1 Group Gives Specific Guidance for Patients
This coalition waiver request adds three additional options for physicians and home health agencies as they endeavor to keep those with […]
CSL continues to provide medicines to patients around the world. Safeguarding our people, patients and donors remains our top priority. […]
Read More… from COVID-19: CSL continues to provide medicines to patients around the world.
STATEMENT UPDATED: March 18, 2020 It is our commitment to provide you with updated guidelines on COVID-19, please find the […]
Read More… from WEDNESDAY, MARCH 18 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
Shortly after the FDA granted an Emergency Use Authorization to its first commercially developed coronavirus test—developed by Roche for use […]
For many immunocompromised people, social distancing isn’t a new endeavor. Alpha-1 Antitrypsin Deficiency is sometimes called an “invisible disability”. This […]
STATEMENT UPDATED: March 12, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from THURSDAY, MARCH 12 COVID-19 Update from the Alpha-1 Foundation & AlphaNet
STATEMENT UPDATED: March 9, 2020 Please note, this statement is specific to the United States. If you are an individual […]
Read More… from COVID-19 Update from the Alpha-1 Foundation & AlphaNet
As the situation with the novel coronavirus rapidly evolves, we wanted to inform you that Grifols is taking measures in […]
Read More… from Grifols Update Regarding the Novel Coronavirus
March 4, 2020- The 2020 Celtic Connection will take place this Saturday, March 7th at the Boston Marriott Newton to […]
Read More… from Don’t be green with envy… Join us this Saturday for the 2020 Celtic Connection
STATEMENT UPDATED: March 2, 2020 The current outbreak of 2019 novel coronavirus (COVID-19) was first identified in China but has […]
Read More… from Update on 2019 novel coronavirus from the Alpha-1 Foundation & AlphaNet
WHO: The Alpha-1 Community! Every Alpha, family member, caregiver, friend, healthcare professional researcher and industry member can participate. The Alpha-1 […]
https://www.alpha1.org/alphas-friends-family/resources/clinical-trials/ A clinical trial is a research study in which one or more human subjects are prospectively assigned to one […]
Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus […]
Read More… from 2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies
Miami, January 31, 2020 – The Alpha-1 Foundation is proud to celebrate its 25th Anniversary. On January 31, 1995, the […]
Read More… from The Alpha-1 Foundation celebrates its 25th anniversary
The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols also received approval by the Danish Medicines Council […]
Read More… from Grifols’s Prolastina approved for use in Denmark
Blood products and vaccines specialist CSL Behring announced that the Danish Medicines Council has published its final decision, approving human […]
Read More… from CSL Behring’s Respreeza gains approval in Denmark
Miami, Jan. 13, 2020 – Jonathan Maidment will return to the trails again in 2020! He is pleased to announce […]
Read More… from Jonathan Maidment goes for the Triple Crown of Hiking
Cold weather conditions can worsen symptoms for lung affected Alphas and for patients with chronic obstructive pulmonary disease (COPD), as […]
Read More… from Q&A: Alphas, seasonal flu and winter wellness
